Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00008060
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council
Testing effectiveness (Phase 2)Study completedNCT00004923
What this trial is testing

Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Yale University 47
Testing effectiveness (Phase 2)Study completedNCT00381797
What this trial is testing

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Who this might be right for
Childhood Cerebral Anaplastic AstrocytomaChildhood OligodendrogliomaChildhood Spinal Cord Neoplasm+3 more
National Cancer Institute (NCI) 97
Testing effectiveness (Phase 2)Study completedNCT00003276
What this trial is testing

Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer

Who this might be right for
Gallbladder Cancer
Alliance for Clinical Trials in Oncology 40
Testing effectiveness (Phase 2)Ended earlyNCT03311750
What this trial is testing

Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Hellenic Cooperative Oncology Group 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06192680
What this trial is testing

Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Harbin Medical University 63
Large-scale testing (Phase 3)UnknownNCT02355119
What this trial is testing

Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Azienda Ospedaliero, Universitaria Pisana 310
Testing effectiveness (Phase 2)Ended earlyNCT00271011
What this trial is testing

Mitomycin C, Irinotecan, and Cetuximab

Who this might be right for
Colorectal Cancer
University of Michigan Rogel Cancer Center 13
Not applicableWithdrawnNCT01847495
What this trial is testing

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

Who this might be right for
Colorectal Cancer
Wake Forest University Health Sciences
Not applicableUnknownNCT05095064
What this trial is testing

Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
University Hospital, Antwerp 60
Testing effectiveness (Phase 2)Study completedNCT01394939
What this trial is testing

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaCRC
Jennerex Biotherapeutics 52
Testing effectiveness (Phase 2)Ended earlyNCT01042028
What this trial is testing

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Per Pfeiffer 39
Not applicableStudy completedNCT02547480
What this trial is testing

LifePearl-Iri Pharmacokinetic Study

Who this might be right for
Metastatic Colorectal CancermCRC
Terumo Europe N.V. 15
Testing effectiveness (Phase 2)Study completedNCT04059562
What this trial is testing

Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Heinrich-Heine University, Duesseldorf 28
Early research (Phase 1)Study completedNCT00020488
What this trial is testing

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT00081536
What this trial is testing

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 105
Testing effectiveness (Phase 2)Study completedNCT04753216
What this trial is testing

Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more
Northwestern University 3
Testing effectiveness (Phase 2)Study completedNCT00137852
What this trial is testing

Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)UnknownNCT01930864
What this trial is testing

Metformin Plus Irinotecan for Refractory Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsAdenocarcinoma
Barretos Cancer Hospital 41
Testing effectiveness (Phase 2)Study completedNCT00389584
What this trial is testing

Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in Adults+4 more
University of California, Davis 30
Next Page